This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesA biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
After-hours moves often reveal the next chapter for crypto firms. Gemini shares rise after hours as investors embrace...
Chevron’s CEO warned that oil prices are still too low given the ongoing Strait of Hormuz disruption. Markets have no...
Lockheed Martin has surged about 26% in 2026. Before you chase the rally, learn how to assess whether the stock still...
As PacBio lays out its Q1 2026 results, investors hunt for catalysts, cadence, and cash runway signals. This guide tr...
Dive into the Via 2026 earnings call with a practical, plain-English read. Learn what the Q1 results could mean for g...
Eli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
Quantum names showed a broad pullback after a sharp rally, with IonQ down about 7% and D-Wave slipping near 8% as inv...
As Endava enters the back half of 2026, the Q3 earnings narrative centers on margin discipline, cloud-led growth, and...
As 2026’s stock-split wave unfolds, investors eye three high-profile names—AutoZone, Grainger, and United Rentals—for...
CoStar Group has agreed to acquire Bora Inc., the parent of Zonda, from MidOcean Partners for $800 million in cash, a...
As Signet gears up for 2026, investors should focus on earnings drivers, margin dynamics, and the evolving omnichanne...